Literature DB >> 21590470

Pediatric sub-specialist controversies in the treatment of congenital heart disease in trisomy 13 or 18.

Andrew R Yates1, Timothy M Hoffman, Edward Shepherd, Bethany Boettner, Kim L McBride.   

Abstract

Trisomy 13 and 18 are associated with congenital heart disease. Cardiac palliation has been reported in the literature, but is not usually done in this population. Thus, a multi-disciplinary team may experience controversy in formulating a care plan that includes cardiac intervention. Our objective was to determine differences in recommendations for cardiac intervention in this population between physicians specializing in pediatric cardiac critical care, neonatology, and genetics. A web-based survey was performed between April 2007 and August 2008. This survey evaluated surgical and transcatheter cardiac palliations that had been performed for individuals with trisomy 13 or 18 at the respondent's institution, the respondent's recommendations for cardiac intervention in hypothetical symptomatic patients with trisomy 13 or trisomy 18 and the influence of parental preference on these recommendations. Eight hundred fifty-nine responses were obtained from a primarily academic practice setting (59%). Cardiologists were most likely to recommend intervention; low risk interventions were recommended by 32% of cardiologists, 7% of neonatologists and 20% of geneticists. Parental request to intervene resulted in a 3 fold increased in the likelihood of all specialist recommending intervention. Counseling of families frequently occurred by multiple sub specialists (50%) and there was frequently (71%) a difference in opinion. Individuals with trisomy 13 or 18 are receiving cardiac intervention at many institutions. Cardiologists were more likely than geneticists or neonatologists to recommend intervention on all heart lesions other than single ventricle palliation which no specialists recommended. Parental wishes that "everything be done" significantly influenced all specialists' recommendations.

Entities:  

Mesh:

Year:  2011        PMID: 21590470     DOI: 10.1007/s10897-011-9373-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  21 in total

1.  Cardiac surgery in the setting of trisomy 13.

Authors:  J Goodship
Journal:  Cardiol Young       Date:  2000-11       Impact factor: 1.093

2.  Risk adjustment for congenital heart surgery: the RACHS-1 method.

Authors:  Kathy J Jenkins
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2004

3.  Natural history of trisomy 18.

Authors:  N D Embleton; J P Wyllie; M J Wright; J Burn; S Hunter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

4.  Population-based analyses of mortality in trisomy 13 and trisomy 18.

Authors:  Sonja A Rasmussen; Lee-Yang C Wong; Quanhe Yang; Kristin M May; J M Friedman
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

5.  Balloon valvuloplasty for critical aortic stenosis in a low birth weight baby with tracheoesophageal fistula.

Authors:  Yu-Ching Lin; Ming-Ren Chen
Journal:  J Formos Med Assoc       Date:  2005-07       Impact factor: 3.282

6.  Survival in trisomy 18.

Authors:  S Root; J C Carey
Journal:  Am J Med Genet       Date:  1994-01-15

7.  Cardiac surgery in a girl with trisomy 13.

Authors:  P Strømme; E Thaulow; O Geiran
Journal:  Cardiol Young       Date:  2000-11       Impact factor: 1.093

8.  Natural history of trisomy 13.

Authors:  J P Wyllie; M J Wright; J Burn; S Hunter
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

9.  Intensive cardiac management in patients with trisomy 13 or trisomy 18.

Authors:  Yukihiro Kaneko; Jotaro Kobayashi; Yusuke Yamamoto; Hitoshi Yoda; Yuki Kanetaka; Yayohi Nakajima; Daiichi Endo; Keiji Tsuchiya; Hajime Sato; Tadashi Kawakami
Journal:  Am J Med Genet A       Date:  2008-06-01       Impact factor: 2.802

10.  Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk.

Authors:  B J Baty; B L Blackburn; J C Carey
Journal:  Am J Med Genet       Date:  1994-01-15
View more
  4 in total

1.  Major anomalies and birth-weight influence NICU interventions and mortality in infants with trisomy 13 or 18.

Authors:  K Acharya; S Leuthner; R Clark; T H Nghiem-Rao; A Spitzer; J Lagatta
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

2.  Parent Perspectives of Support Received from Physicians and/or Genetic Counselors Following a Decision to Continue a Pregnancy with a Prenatal Diagnosis of Trisomy 13/18.

Authors:  Stephanie E Wallace; Sara Gilvary; Michael J Smith; Siobhan M Dolan
Journal:  J Genet Couns       Date:  2017-10-27       Impact factor: 2.537

3.  Genetic Basis of Human Congenital Heart Disease.

Authors:  Shannon N Nees; Wendy K Chung
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-09-01       Impact factor: 9.708

4.  Experiences of children with trisomy 18 referred to pediatric palliative care services on two continents.

Authors:  Jonathan Mullin; Joanne Wolfe; Myra Bluebond-Langner; Finella Craig
Journal:  Am J Med Genet A       Date:  2019-04-01       Impact factor: 2.802

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.